Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Histologically confirmed metastatic castration-resistant prostate cancer; 2. Two or more bone metastases were found in the bone scan, and there was no known visceral metastasis, or there was lymph node metastasis but the minor axis diameter was less than 3cm; 3. Regardless of whether they had received docetaxel chemotherapy or not.
Exclusion criteria
Exclusion criteria: 1. Received chemotherapy or did not recover from adverse events caused by chemotherapy in the past 4 weeks; 2. Previous half-body extracorporeal radiotherapy and received whole-body radiotherapy in the past 24 weeks; 3. Blood transfusion or erythropoietin stimulant was used in the past 4 weeks; 4. Imminent or confirmed compression of the spinal cord.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum standard uptake value;Progression Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;Clinical benefit rate;overall survival; | — |
Countries
China
Contacts
Fudan University Shanghai Cancer Center